Adaptive Biotechnologies Corporation (ADPT)
USD 5.97
(-8.44%)
USD 5.97
(-8.44%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -156.32 Million | -183.94 Million | -192.72 Million | -149.68 Million | 205.4 Million | -32.25 Million |
| Net Income | -225.25 Million | -200.36 Million | -207.29 Million | -146.22 Million | -68.6 Million | -46.44 Million |
| Depreciation & Amortization | 22.23 Million | 20.92 Million | 13.95 Million | 8.47 Million | 7.79 Million | 6 Million |
| Deferred income taxes | -60.92 Million | - | 7.23 Million | 773 Thousand | -1.88 Million | -1.24 Million |
| Stock-based compensation | 62.9 Million | 55.47 Million | 43.25 Million | 24.76 Million | 13.12 Million | 11.14 Million |
| Change in working capital | -46.18 Million | -71.54 Million | -56.81 Million | -40.79 Million | 254.93 Million | -1.72 Million |
| Other non-cash items | 90.89 Million | 11.57 Million | 6.95 Million | 3.33 Million | 43 Thousand | 5000.00 |
| Investing Cash Flow | 129.64 Million | 2.9 Million | 181.21 Million | -117.04 Million | -481.69 Million | 736 Thousand |
| Investments in PPE | -10.69 Million | -16.34 Million | -61.74 Million | -18.8 Million | -11.2 Million | -6.31 Million |
| Acquisitions | - | -19.25 Million | -181.21 Million | 98.24 Million | 470.49 Million | 19 Thousand |
| Investment purchases | -429.55 Million | -278.77 Million | -316.54 Million | -694.96 Million | -884.21 Million | -146.5 Million |
| Sales/Maturities of investments | 569.9 Million | 298.03 Million | 559.5 Million | 596.72 Million | 413.72 Million | 153.53 Million |
| Other Investing Activities | -1.00 | 19.25 Million | 181.21 Million | -98.24 Million | -470.49 Million | 19 Thousand |
| Financing Cash Flow | 2.24 Million | 132.26 Million | 27.14 Million | 293.58 Million | 319.91 Million | 1.24 Million |
| Debt repayment | - | -124.37 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 2.24 Million | 7.89 Million | 26.71 Million | 272.16 Million | 320.85 Million | 1.26 Million |
| Other Financing Activities | 2.24 Million | 248.75 Million | 27.14 Million | 21.42 Million | -934 Thousand | 1.24 Million |
| Accounts receivables | 2.03 Million | -22.64 Million | -7.36 Million | 2.61 Million | -7.81 Million | 775 Thousand |
| Accounts payables | -5.4 Million | 7.11 Million | 5.22 Million | 5.24 Million | -2.42 Million | 1.86 Million |
| Inventory | -2.83 Million | 817 Thousand | -5.2 Million | -4.99 Million | -1.23 Million | -3.04 Million |
| Other working capital | -39.97 Million | -56.82 Million | -49.48 Million | -43.66 Million | 266.4 Million | -1.31 Million |
| Cash at beginning of period | 90.03 Million | 141.2 Million | 125.57 Million | 98.71 Million | 55.09 Million | 85.36 Million |
| Cash at end of period | 65.06 Million | 92.42 Million | 141.2 Million | 125.57 Million | 98.71 Million | 55.09 Million |
| Capital Expenditure | -10.69 Million | -16.34 Million | -61.74 Million | -18.8 Million | -11.2 Million | -6.31 Million |
| Effect of forex changes on cash | -201.32 Million | - | - | - | - | - |
| Net cash flow / Change in cash | -24.96 Million | -48.77 Million | 15.62 Million | 26.86 Million | 43.62 Million | -30.27 Million |
| Free Cash Flow | -167.02 Million | -200.29 Million | -254.47 Million | -168.48 Million | 194.2 Million | -38.57 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -46.22 Million | -47.53 Million | -225.25 Million | -69.44 Million | -50.32 Million | -47.81 Million |
| Depreciation & Amortization | 5 Million | 5.21 Million | 22.23 Million | 5.39 Million | 5.76 Million | 5.65 Million |
| Deferred income taxes | - | - | -60.92 Million | -23.79 Million | -2.52 Million | -2.24 Million |
| Stock-based compensation | 12.95 Million | 14.29 Million | 62.9 Million | 15.55 Million | 15.33 Million | 17.34 Million |
| Change in working capital | 2.82 Million | -10.3 Million | -46.18 Million | -3.51 Million | -18.64 Million | 449 Thousand |
| Other non-cash items | 25.09 Million | 2.36 Million | 90.89 Million | 48.86 Million | 3.71 Million | 3.04 Million |
| Investing Cash Flow | 5.87 Million | 44.5 Million | 129.64 Million | 3.2 Million | 26.13 Million | 37.32 Million |
| Investments in PPE | -1.72 Million | -1.51 Million | -10.69 Million | -1.29 Million | -2.77 Million | -3.69 Million |
| Acquisitions | - | - | - | -4.5 Million | -28.91 Million | -41.02 Million |
| Investment purchases | -82.71 Million | -53.48 Million | -429.55 Million | -121.99 Million | -119.08 Million | -99.38 Million |
| Sales/Maturities of investments | 90.32 Million | 99.5 Million | 569.9 Million | 126.5 Million | 148 Million | 140.4 Million |
| Other Investing Activities | 7.6 Million | 46.02 Million | -1.00 | 4.5 Million | 28.91 Million | 41.02 Million |
| Financing Cash Flow | 30 Thousand | 44 Thousand | 2.24 Million | 87 Thousand | 17 Thousand | 1.46 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 30 Thousand | 44 Thousand | 2.24 Million | 87 Thousand | 17 Thousand | 1.46 Million |
| Other Financing Activities | 30 Thousand | 44 Thousand | 2.24 Million | 87 Thousand | 17 Thousand | 1.46 Million |
| Accounts receivables | 6.41 Million | -4.05 Million | 2.03 Million | -6.76 Million | 334 Thousand | -621 Thousand |
| Accounts payables | 407 Thousand | -3.94 Million | -5.4 Million | 5.33 Million | -7.13 Million | 8.65 Million |
| Inventory | -818 Thousand | 1.11 Million | -2.83 Million | 3.97 Million | -273 Thousand | 65 Thousand |
| Other working capital | -3.17 Million | -4.94 Million | -39.97 Million | -6.06 Million | -11.56 Million | -7.65 Million |
| Cash at beginning of period | 71.23 Million | 67.99 Million | 90.03 Million | 88.71 Million | 112.16 Million | 96.92 Million |
| Cash at end of period | 59.82 Million | 74.19 Million | 65.06 Million | 65.06 Million | 91.63 Million | 112.16 Million |
| Capital Expenditure | -1.72 Million | -1.51 Million | -10.69 Million | -1.29 Million | -2.77 Million | -3.69 Million |
| Effect of forex changes on cash | - | - | -201.32 Million | -11 Thousand | -8.67 Million | -40.04 Million |
| Net cash flow / Change in cash | -11.4 Million | 6.2 Million | -24.96 Million | -23.64 Million | -20.52 Million | 15.23 Million |
| Free Cash Flow | -19.03 Million | -39.86 Million | -167.02 Million | -28.23 Million | -49.46 Million | -27.25 Million |
HCI
REPYF
YFI
POW
EXSPF
YAMCF